通过检验发现癌症的BRCA2基因突变
|
By LabMedica International staff writers Posted on 19 Mar 2018 |
|
图片：子宫内膜样卵巢癌显示BRCA2的核染色（右半部）；子宫内膜样卵巢癌BRCA2阴性染色（左半部）（图片蒙德克萨斯大学MD安德森癌症中心惠赐）。
临床基因检验发现了乳腺癌易感基因2 (BRCA2)的许多意义不明变异(VUS)。VUS形成一项严重的临床挑战，因为这些变体对癌症风险的促进作用尚不明确。
刚开发成功的一款检验产品能显示BRCA2基因里的哪些突变使妇女易生乳腺癌或卵巢癌。这款基于实验室的检验产品能确定BRCA2基因里的哪些遗传性VUS突变与癌症形成有关。
美国明尼苏达州罗彻斯特市梅奥诊所的科学家及其同事使用经过确证的BRCA2同源重组(HR) DNA修复活性的功能性测定全面评估了BRCA2 C末端DNA结合域(DBD)里的VUS，并定义了变异致病性的分类器。
在评估的139种变异中，54种的致病概率大于等于99%，73种的中性概率大于等于95%。比较功能性测定的结果与Align-GVGD蛋白序列预测算法预测变异致病性的结果，该算法以前一直用于变异的分类。相较HR测定，Align-GVGD预测的致病变异严重过头。
科研小组随后在一个贝叶斯分级模型(VarCall)中结合功能性测定与Align-GVGD的预测结果，估计每种VUS的总体致病概率。此外，为了预测所有其它BRCA2 DBD变异的作用，并优选供功能性研究的变异，他们用内表现型优化的序列集合(endoPhenotype-Optimized Sequence Ensemble, ePOSE)算法和HR功能性测定的数据训练BRCA2变异的分类器。
这项研究的高级研究员Fergus J. Couch博士说：“迄今为止，我们只能确定BRCA2基因中的13个遗传性突变致癌。本次研究发现了54种突变会增加癌症风险。已知不会增加癌症风险的21个中性突变现在增加到73个。这些发现也许能帮助患者和医院更好地决定如何处理基因检验获得的信息。”该研究的论文发表于2018年1月25日的《美国人类遗传学杂志》(American Journal of Human Genetics)。
Related Links:
梅奥诊所
刚开发成功的一款检验产品能显示BRCA2基因里的哪些突变使妇女易生乳腺癌或卵巢癌。这款基于实验室的检验产品能确定BRCA2基因里的哪些遗传性VUS突变与癌症形成有关。
美国明尼苏达州罗彻斯特市梅奥诊所的科学家及其同事使用经过确证的BRCA2同源重组(HR) DNA修复活性的功能性测定全面评估了BRCA2 C末端DNA结合域(DBD)里的VUS，并定义了变异致病性的分类器。
在评估的139种变异中，54种的致病概率大于等于99%，73种的中性概率大于等于95%。比较功能性测定的结果与Align-GVGD蛋白序列预测算法预测变异致病性的结果，该算法以前一直用于变异的分类。相较HR测定，Align-GVGD预测的致病变异严重过头。
科研小组随后在一个贝叶斯分级模型(VarCall)中结合功能性测定与Align-GVGD的预测结果，估计每种VUS的总体致病概率。此外，为了预测所有其它BRCA2 DBD变异的作用，并优选供功能性研究的变异，他们用内表现型优化的序列集合(endoPhenotype-Optimized Sequence Ensemble, ePOSE)算法和HR功能性测定的数据训练BRCA2变异的分类器。
这项研究的高级研究员Fergus J. Couch博士说：“迄今为止，我们只能确定BRCA2基因中的13个遗传性突变致癌。本次研究发现了54种突变会增加癌症风险。已知不会增加癌症风险的21个中性突变现在增加到73个。这些发现也许能帮助患者和医院更好地决定如何处理基因检验获得的信息。”该研究的论文发表于2018年1月25日的《美国人类遗传学杂志》(American Journal of Human Genetics)。
Related Links:
梅奥诊所
Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Automated MALDI-TOF MS System
EXS 3000
Gold Member
Hybrid Pipette
SWITCH
Latest 分子诊断 News
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read more
Molecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channel
Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Microbiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more
AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
Pathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read more
Technology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read more
Aptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channel
New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more